Page 4 - Isk Bioscience News Today

SK bioscience is stepping up work on a nasal spray to prevent and treat COVID-19.

SK bioscience to develop antiviral nasal spray

SK bioscience ready to seek M&As

Richard Pazdur, M.D., director of the FDA's Oncology Center of Excellence, defended the agency's rejection of Eli Lilly and Innovent Biologics' PD-1 inhibitor. The U.S.

New Zealand will now allow in international travellers from May 1, without quarantine measures; Samoa sees scores of infections in first community outbreak.

Govt preorders locally made COVID-19 vaccines from SK bioscience

SEOUL, March 21 — South Korea has reached a deal to buy 10 million doses of the country’s first experimental coronavirus vaccine, developed by SK Bioscience Co Ltd, authorities said today. The South Korean company has since August conducted Phase 3 trials of its vaccine candidate, codenamed...

Seoul: As flurona, which means having both COVID-19 and influenza at the same time, is recently popping up in many countries, including Israel, Brazil, the U.S., Hungary, and Croatia, concerns on...

SK chemicals keeping mum on legal battle with shareholders

SEOUL, South Korea (AP) — South Korea will begin offering Novavax Inc.s COVID-19...